These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25523631)

  • 21. Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma.
    Wang L; Jiang H; Li W; Jia C; Zhang H; Sun Y; Chen X; Song X
    Arch Oral Biol; 2017 Jan; 73():105-112. PubMed ID: 27744260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
    de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
    Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance.
    Tu HF; Lin SC; Chang KW
    Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):104-11. PubMed ID: 23340306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
    Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
    Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
    Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
    Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways.
    Cui J; Yuan Y; Shanmugam MK; Anbalagan D; Tan TZ; Sethi G; Kumar AP; Lim LHK
    Int J Biol Sci; 2021; 17(15):4254-4270. PubMed ID: 34803496
    [No Abstract]   [Full Text] [Related]  

  • 33. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC).
    Mutallip M; Nohata N; Hanazawa T; Kikkawa N; Horiguchi S; Fujimura L; Kawakami K; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Mol Med; 2011 Mar; 27(3):345-52. PubMed ID: 21181092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.
    Anbalagan D; Yap G; Yuan Y; Pandey VK; Lau WH; Arora S; Bist P; Wong JS; Sethi G; Nissom PM; Lobie PE; Lim LH
    PLoS One; 2014; 9(12):e114507. PubMed ID: 25536365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
    Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
    Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts.
    Álvarez-Teijeiro S; Menéndez ST; Villaronga MÁ; Rodrigo JP; Manterola L; de Villalaín L; de Vicente JC; Alonso-Durán L; Fernández MP; Lawrie CH; García-Pedrero JM
    Sci Rep; 2017 Dec; 7(1):17785. PubMed ID: 29259267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
    Kinoshita T; Hanazawa T; Nohata N; Kikkawa N; Enokida H; Yoshino H; Yamasaki T; Hidaka H; Nakagawa M; Okamoto Y; Seki N
    Oncotarget; 2012 Nov; 3(11):1386-400. PubMed ID: 23159910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.
    Koshizuka K; Hanazawa T; Kikkawa N; Arai T; Okato A; Kurozumi A; Kato M; Katada K; Okamoto Y; Seki N
    Cancer Sci; 2017 Aug; 108(8):1681-1692. PubMed ID: 28612520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
    Kumar B; Yadav A; Lang J; Teknos TN; Kumar P
    PLoS One; 2012; 7(5):e37601. PubMed ID: 22629428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Hanazawa T; Kikkawa N; Yamamoto N; Yoshino H; Itesako T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Nov; 109(10):2636-45. PubMed ID: 24091622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.